Paper · 304759

Immunologic reactivity in patients with primary operable breast cancer.

Wanebo HJ and 7 others. Cancer, 1978. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Immunologic reactivity in patients with primary operable breast cancer. Papers, record 304759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/304759

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Immunologic reactivity in patients with primary operable breast cancer.; PubMed
Journal: Cancer; PubMed
Year: 1978; PubMed
Publication types: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/304759/; PubMed
DOI: https://doi.org/10.1002/1097-0142(197801)41:1<84::aid-cncr2820410113>3.0.co;2-x; PubMed
The journal: https://conductscience.org/library/journal-index/0374236; PubMed
Citations, by iCite: 38; iCite
Relative citation ratio, by iCite: 1.91; iCite
Revised in PubMed: 2020-12-09; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Wanebo HJ	H J
2	Thaler HT	H T
3	Hansen JA	J A
4	Rosen PP	P P
5	Robbins GF	G F
6	Urban JA	J A
7	Oettgen HF	H F
8	Good RA	R A

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Breast Neoplasms	Major topic
Immunity	Major topic
B-Lymphocytes
Breast Diseases
Dinitrochlorobenzene
Female
Humans
Immunoglobulins
In Vitro Techniques
Lectins
Leukocyte Count
Lymphatic Metastasis
Lymphocyte Activation
Male
Middle Aged
Prognosis
Skin Tests
T-Lymphocytes

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMID	Title	Journal	Year	In Papers	Source
8,318,418	Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.	Br J Cancer	1993	https://conductscience.org/library/papers/8318418	PubMed
6,965,822	Immunomorphologic lymph node changes in rats bearing experimental breast tumors.	Am J Pathol	1980	https://conductscience.org/library/papers/6965822	PubMed
6,352,007	Serial immune function testing to predict clinical disease relapse in patients with solid tumors.	Cancer Immunol Immunother	1983	https://conductscience.org/library/papers/6352007	PubMed
6,231,310	Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.	J Clin Invest	1984	https://conductscience.org/library/papers/6231310	PubMed
2,359,208	Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.	Jpn J Surg	1990	https://conductscience.org/library/papers/2359208	PubMed
1,417,176	Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.	Ann Surg	1992	https://conductscience.org/library/papers/1417176	PubMed
444,917	Monocyte maturation and prognosis in primary breast cancer.	Br Med J	1979	https://conductscience.org/library/papers/444917	PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/304759

GET https://conductscience.org/api/papers/v1/304759/authors

API reference For AI assistants